Key takeaway: The investor presentation by Galaxy Surfactants Limited detailed the unaudited financial results for the quarter ended June 30, 2026. Management reported a consolidated revenue of ₹1,785.2 crore, reflecting a 38.5% year-over-year increase. EBITDA grew by 87% to ₹252.5 crore, with an EBITDA margin of 14.1%. The presentation highlighted a mid-single-digit volume growth across both Performance Surfactants and Specialty Care segments. India experienced a return to double-digit volume growth, while the AMET region faced a low-single-digit decline due to geopolitical disruptions. Management emphasized the company's ability to manage risks and volatility, noting strong customer demand and operational excellence as key factors in their performance. The document also included a discussion on raw material price volatility and the company's risk management practices.

Key takeaway: Galaxy Surfactants Limited held its Q4 and FY 2025-26 Earnings Conference Call on May 15, 2026, where management discussed the impact of external disruptions on global supply chains, particularly due to geopolitical tensions in West Asia. The company reported an 8% year-on-year volume growth in India, driven by strong demand in both Tier 1 and non-Tier 1 accounts, while specialty volumes grew by over 27%. However, the AMET region faced a 15% decline in volumes due to logistical challenges and customer repricing pressures. Financially, Q4 EBITDA was reported at INR122 crores, down from INR135 crores in the previous year. Management highlighted ongoing innovation efforts, including the launch of a new surfactant product, and expressed confidence in the company's resilience and customer relationships despite recent challenges. They set a Q1 volume growth guidance of 6% to 8%.

Key takeaway: The investor presentation by Galaxy Surfactants Limited detailed the audited financial results for the quarter and year ended March 31, 2026. Management reported that Q4FY26 EBITDA was ₹122 crore, a decrease from ₹135 crore in Q4FY25, with EBITDA per metric ton at ₹20,113 compared to ₹21,715 the previous year. The company noted resilient performance in India, with high single-digit volume growth driven by Specialty Care Products. However, the AMET region experienced a mid-teens decline in volumes due to geopolitical disruptions. For FY26, total revenue increased by 24% to ₹5,270.4 crore, while EBITDA dropped by 3% to ₹497 crore. Management highlighted challenges from supply-side disruptions but expressed confidence in navigating these through pricing actions and strong customer partnerships. The presentation also included a summary of segment performance, with Specialty Care showing growth while Performance Surfactants faced declines.

Key takeaway: Management reported that Galaxy Surfactants Limited faced multiple headwinds in Q3 FY 2025-26, including reformulation pressures from a key customer, temporary demand disruptions due to GST rate rationalization, and reciprocal tariffs impacting specialty segment exports. Despite these challenges, management highlighted a positive development with a reduction in U.S. tariffs on Indian exports, which is anticipated to enhance competitiveness in the U.S. market. For Q3, consolidated volumes remained stable year-on-year, with a high single-digit decline in Performance Surfactants offset by growth in the Specialty segment. EBITDA before exceptional items increased by 13% year-on-year. Management noted that the domestic market showed mid-single-digit growth, while AMET faced a double-digit decline. The company launched five new products and refreshed its brand identity, aiming to expand into beauty and wellness segments. Management expressed confidence in regaining growth momentum in the coming quarters.

Key takeaway: The investor presentation by Galaxy Surfactants Limited, dated February 13, 2026, provided an overview of the unaudited financial results for the quarter and nine months ended December 31, 2025. Management reported a resilient performance in Q3FY26, with consolidated volumes remaining flat year-on-year, while the Specialty Care Products segment experienced high single-digit growth. EBITDA increased by 13% year-on-year to Rs 124 crore, attributed to stronger contributions from the Specialty segment. Domestic volumes in India grew in the mid-single digits, driven by traction from Non-Tier-1 and D2C customers. However, the Performance Surfactants segment faced a decline due to reformulation at a key account. The presentation highlighted ongoing efforts to strengthen capacities and expand globally, particularly in Latin America, Asia-Pacific, North America, and Europe. Management expressed confidence in regaining growth momentum in the coming quarters.